Table 3.
CSF-TRUST (n) |
|||||||||
---|---|---|---|---|---|---|---|---|---|
Method | Titre | − | 1 : 1 | 1 : 2 | 1 : 4 | 1 : 8 | 1 : 16 | ≥1 : 32 | Subtotal |
CSF-VDRL (n) | − | 620 | 0 | 620 | |||||
1 : 1 | 19 | 28 | 2 | 49 | |||||
1 : 2 | 2 | 25 | 24 | 2 | 53 | ||||
1 : 4 | 1 | 2 | 19 | 18 | 1 | 41 | |||
1 : 8 | 0 | 20 | 16 | 1 | 37 | ||||
1 : 16 | 2 | 10 | 7 | 0 | 19 | ||||
≥1 : 32 | 1 | 3 | 1 | 5 | |||||
Subtotal | 642 | 55 | 45 | 42 | 28 | 11 | 1 | 824 |
Shadowed boxes indicate samples with identical titres of CSF-VDRL and CSF-TRUST.
Open boxes indicate samples having twofold dilution difference between CSF-VDRL and CSF-TRUST.
Upward diagonals indicate CSF-VDRL-reactive, but CSF-TRUST non-reactive (n=22).
Horizontal strike boxes indicate that CSF-VDRL titres are significantly higher than CSF-TRUST titres (n=5).
−, Negative; CSF-TRUST, toluidine red unheated serum test on cerebrospinal fluids; CSF-VDRL, venereal disease research laboratory test on cerebrospinal fluids.